Glenmark Pharmaceuticals wins Thomson Reuters India Innovation Award

Thomson Reuters India Innovation Awards 2013 was recently held in New Delhi. The awards recognised the most innovative academic institutions and commercial enterprises headquartered in India for their spirit of innovation in Research & Development (R&D). Pharma Corporate award went to Glenmark Pharmaceuticals, Pharma Academic & Government award to National Institute of Immunology, Hi-Tech Corporate award to Reliance Industries and Hi-Tech Academic & Government to Council of Scientific & Industrial Research.

Commenting on their recognition in the Hi-Tech Academic & Government category, Professor Samir K Brahmachari, Director General, Council of Scientific & Industrial Research said, “CSIR today is globally benchmarked and is recognised as a successful model of post independence India’s innovation system that provides globally competitive, affordable technological solutions to diverse sectors, from leather to generic drugs, pesticides to tractors, glass and ceramics to industrial catalysts, and from minerals and metals to advance materials.”

Winner of the Pharma Academic & Government category, Dr Chandrima Shaha, Director, National Institute of Immunology, added, “We would like to make a difference to the nation by developing innovative technologies in the laboratory through discoveries spawned by basic scientific inquiry and developing them for use by the society. Our aspirations are to solve daunting problems in health emerging in modern times.”

The guest of honour at the event was Dr T Ramasami, Secretary, Government of India, Department of Science & Technology. The ceremony was attended by more than 150 guests comprising researchers, scientists and heads of pharmaceutical and technology companies, academics, intellectual property (IP) analysts and searchers, and patent examiners.

EP News Bureau – Mumbai